.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Identify first generic entrants
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Federal Trade Commission
Queensland Health
Daiichi Sankyo
Johnson and Johnson
Cantor Fitzgerald
Baxter
Healthtrust
Accenture
McKesson
Farmers Insurance

Generated: July 27, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019826

« Back to Dashboard
NDA 019826 describes THEOPHYLLINE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER, which is a drug marketed by B Braun and is included in two NDAs. It is available from one supplier. Additional details are available on the THEOPHYLLINE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER profile page.

The generic ingredient in THEOPHYLLINE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER is theophylline. There are thirty-six drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the theophylline profile page.

Summary for NDA: 019826

Tradename:
6
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Respiratory Tract Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 019826

Ingredient-typeXanthines

Suppliers and Packaging for NDA: 019826

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
THEOPHYLLINE 0.04% AND DEXTROSE 5% IN PLASTIC CONTAINER
theophylline
INJECTABLE;INJECTION 019826 NDA B. Braun Medical Inc. 0264-9554 0264-9554-10 24 CONTAINER in 1 CASE (0264-9554-10) > 500 mL in 1 CONTAINER
THEOPHYLLINE 0.08% AND DEXTROSE 5% IN PLASTIC CONTAINER
theophylline
INJECTABLE;INJECTION 019826 NDA B. Braun Medical Inc. 0264-9554 0264-9554-10 24 CONTAINER in 1 CASE (0264-9554-10) > 500 mL in 1 CONTAINER

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength40MG/100ML
Approval Date:Aug 14, 1992TE:APRLD:Yes

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength80MG/100ML
Approval Date:Aug 14, 1992TE:APRLD:Yes

Summary for product number 003

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength160MG/100ML
Approval Date:Aug 14, 1992TE:APRLD:Yes


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

McKinsey
Baxter
Cantor Fitzgerald
Merck
Farmers Insurance
McKesson
Healthtrust
Boehringer Ingelheim
Harvard Business School
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot